GALENA BIOPHARMA INC's ticker is and the CUSIP is 363256958. A total of 3 filers reported holding GALENA BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $74,000 | -68.8% | 210,900 | -58.5% | 0.00% | -66.7% |
| Q2 2016 | $237,000 | +690.0% | 508,100 | +2220.1% | 0.00% | – |
| Q1 2016 | $30,000 | -97.7% | 21,900 | -97.5% | 0.00% | -100.0% |
| Q4 2015 | $1,278,000 | +3.6% | 869,200 | +11.3% | 0.02% | -11.8% |
| Q3 2015 | $1,234,000 | -22.4% | 781,100 | -16.5% | 0.02% | -22.7% |
| Q2 2015 | $1,591,000 | +100.9% | 935,800 | +64.1% | 0.02% | +83.3% |
| Q1 2015 | $792,000 | -33.3% | 570,100 | -27.5% | 0.01% | -33.3% |
| Q4 2014 | $1,188,000 | -46.5% | 786,500 | -27.1% | 0.02% | -47.1% |
| Q3 2014 | $2,222,000 | -64.2% | 1,078,700 | -46.9% | 0.03% | -64.6% |
| Q2 2014 | $6,215,000 | +40.8% | 2,031,200 | +15.0% | 0.10% | +29.7% |
| Q1 2014 | $4,415,000 | +47.3% | 1,766,100 | +192.3% | 0.07% | +64.4% |
| Q4 2013 | $2,997,000 | +940.6% | 604,300 | +376.2% | 0.04% | +650.0% |
| Q3 2013 | $288,000 | +487.8% | 126,900 | +474.2% | 0.01% | +500.0% |
| Q2 2013 | $49,000 | – | 22,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|